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RNA interferenceic stem (mES) cells derived from the blastocyst of the preimplantation embryo
can be induced to differentiate in vitro along different cell lineages. However the molecular and cellular
factors that signal and/or determine the expression of key genes, and the localisation of the encoded proteins,
during the differentiation events are poorly understood. One common mechanism by which proteins can be
targeted to speciﬁc regions of the cell is through the asymmetric localisation of mRNAs and Staufen, a
double-stranded RNA binding protein, is known to play a direct role in mRNA transport and localisation. The
aims of the present study were to describe the expression of Staufen in preimplantation embryos and mES
cells and to use RNA interference (RNAi) to investigate the roles of Staufen1 in mES cell lineage
differentiation. Western blotting and immunocytochemistry demonstrated that Staufen is present in the
preimplantation mouse embryo, pluripotent mES cells and mES cells stimulated to differentiate into
embryoid bodies, but the Staufen staining patterns did not support asymmetric distribution of the protein.
Knockdown of Staufen1 gene expression in differentiating mES cells reduced the synthesis of lineage-speciﬁc
markers including Brachyury, α-fetoprotein (AFP), PAX-6, and Vasa. There was however no signiﬁcant change
in either the gene expression of Nanog and Oct4, or in the synthesis of SSEA-1, all of which are key markers of
pluripotency. These data indicate that inhibition of Staufen1 gene expression by RNAi affects an early step in
mES cell differentiation and suggest a key role for Staufen in the cell lineage differentiation of mES cells.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Embryonic stem cells (ES cells) originate from preimplantation
embryos and are generally derived from the inner cell mass or epiblast
of blastocyst stage embryos [1]. Under deﬁned culture conditions they
can be maintained either as a pluripotent population of cells or
induced to differentiate along different lineages [2–4]. With the
increasing interest in stem cell based therapies an understanding of
the basic cellular andmolecular cues involved in the development and
differentiation of ES cells is clearly important. Although considerable
advances have been made in the identiﬁcation of genes expressed
during pluripotency and early mammalian development [5–7] the
post-transcriptional control mechanisms determining their expres-
sion patterns have yet to be fully deﬁned.
The extent to which differentiation of a pluripotent ES cell along
different cell lineages is the result of signals derived from the cellular
environment or fromasymmetric cell division is still actively debated [8].
In organisms such as Caenorhabditis elegans or Drosophila melanogaster,: +44 (0)191 2227424.
l rights reserved.asymmetric cell division has been shown to play an important role in
early development and differentiation [8–10]. This involves the segrega-
tion of proteins that are associated with the activation of a speciﬁc
determinant signalling pathway. For example, in Drosophila, differentia-
tion of a neuroblast into a ganglionmother cell involves asymmetric cell
division that requires segregation of the transcription factor Prospero
through localisation of its mRNA [11–14]. This process also involves
Staufen, which is a member of a family of double-stranded RNA (dsRNA)
binding proteins involved in the transport and/or localisation of mRNAs
to different subcellular compartments and organelles.
Staufen was ﬁrst reported to be involved in the localisation of
different mRNAs during the early development of Drosophila [15]. Since
then the protein has also been reported to function in localising mRNAs
to the vegetal pole of Xenopus oocytes and in lineage speciﬁcation [16].
Further support for Staufenbeing a signiﬁcant factor in cell development
and differentiation is provided through its roles in the survival and
migration of primordial germ cells during the development of zebraﬁsh
embryos [17]. In the mammal Staufen expression has been reported
previously in mouse germ cells [18], but to date the actual roles of the
RNA binding protein in the development and differentiation of
mammalian embryonic cells have not been explored.
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acid sequence identity and known as Staufen1 and Staufen2
respectively, have been identiﬁed. Moreover both genes are associated
with Staufen isoforms produced by alternative splicing. Staufen1,
associated with at least two isoforms of 55 and 63 kDa respectively, is
expressed ubiquitously in mature tissues whereas Staufen2 expres-
sion, which is associated with three isoforms of 62, 59 and 52 kDa, is
restricted to neurones [19]. In transfected cells Staufen has been
shown to be partially associated with the rough endoplasmic
reticulum [20,21], and both Staufen1 and Staufen2 proteins have
been shown to shuttle between the nucleus and cytoplasm, suggest-
ing a role in RNA export [22–24]. However mammalian Staufen1 is
also a member of a protein family functioning in mRNA decay, with
Staufen1-mediated mRNA decay involving the nonsense-mediated
mRNA factor Upf1 [25]. This function presumably precludes the
synthesis of truncated proteins whose activities are harmful to the
cell. Recent work in human cells, speciﬁcally embryonic kidney (HEK)
293T cells has, interestingly, shown that Staufen1 and Staufen2
associate with distinct but overlapping subsets of mRNAs and play
complementary roles in the regulation of cellular metabolism and
physiological processes [26].
The aims of the present work were to determine and describe the
expression of Staufen in embryonic cells, speciﬁcally preimplantation
embryos and mouse ES cells, and to explore the role of the Staufen1
protein in mES cell differentiation using RNAi mediated knockdown of
Staufen1 gene expression. We report that Staufen is synthesised
throughout preimplantation development and in mES cells, and
critically that siRNA knockdown of Staufen1 gene expression reduces
the synthesis of speciﬁc markers associated with mES cell lineage
differentiation. These results provide evidence that Staufen1 plays a
key role in the mechanisms determining the differentiation of
mammalian ES cells.
2. Methods
2.1. Cell culture
Themouse embryonic stem (mES) cell lines CGR8 andmTert (CGR8
stably transfected with GFP reporter and under the control of the
telomerase promoter) [27], were cultured on gelatin (0.1%) coated
tissue culture ﬂasks, incubated at 37 °C with 5% CO2 [28] and routinely
passaged every 2–3 days. The cells were maintained in Glasgow
Minimum Essential Medium (Invitrogen) containing 10% foetal calf
serum (Harlan Sera-Lab Ltd), 0.25% sodium bicarbonate (BDH), 0.1mM
non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate
and 0.1 mM 2-mercaptoethanol (all Invitrogen). To maintain the
undifferentiated state, 10 ng/ml of leukemia inhibitory factor (LIF)
(Chemicon) was added to the media in the ﬂasks [29]. In addition, the
mTert cells were maintained in G418 (Sigma) at a ﬁnal concentration
of 400 μg/ml. In order to form embryoid bodies mouse ES cells were
seeded, 2×106 cells, into 90 mm bacterial Petri dishes containing
10 ml of media lacking LIF. Medium was replaced every 2 days.
Caco-2 cells, a human intestinal cell line, and IEC-6 cells, a rodent
immature intestinal cell line that has characteristics of stem cell-like
crypt cells were cultured as described previously [30].
For cell counting, proliferating cells were harvested by trypsinisa-
tion and live cells counted using the Trypan Blue exclusion method.
Essentially equal volumes of cell suspension and Trypan Blue solution
(Sigma) were mixed together and the number of cells excluding
Trypan Blue counted using a haemocytometer.
2.2. siRNAs and transfection
All siRNAs were obtained pre-annealed (Eurogentec) and included
Staufen1 siRNA, mutated Staufen1 siRNA (siRNAmut) and a proprie-
tary GFP siRNA:siRNA sense: 5′ CAACUGUACUACCUUUCCATT 3′
siRNA antisense: 3′ TTGUUGACAUGAUGGAAAGGU 5′
siRNA mut sense: 5′ CAACUGCAUUACUCUUCCATT 3′
siRNA mut antisense: 3′ TTGUUGACGUAAUGAGAAGGU 5′
The GFP andmutated siRNAswere used as negative controls. For all
experiments the stock siRNA solutions, diluted to 20mM in RNase free
water, were further diluted 1:40 in Opti-MEM® I reduced serum
medium (Invitrogen); Lipofectamine™ 2000 (Invitrogen) was diluted
1:50 in the same medium and after 15 min of incubation at room
temperature the siRNA and the Lipofectamine™ 2000 aliquots were
combined, incubated a further 15 min at room temperature and the
complexes added to the cells (5×105 cells for experiments conducted
on 6-well plates). Cells and siRNA were incubated together at 37 °C in
an atmosphere of 5% CO2. Protein knockdown was assessed at 48 h
post transfection and for longer experiments investigating differentia-
tion, the media were replaced every 2–3 days.
2.3. RNA isolation, reverse transcriptase and real-time PCR analysis
ES cells and embryoid bodies were washed twice in phosphate
buffered saline (PBS) and total RNA extracted with Trizol (Invitrogen).
cDNA synthesis was performed from 3 μg of total RNA at 50 °C for 1 h
using random primers and Superscript II Reverse Transcriptase (RT)
(Invitrogen).
The gene speciﬁc primers forward (F) and reverse (R) used in the
RT-PCR reactions are as follows:
Staufen1:
Forward: 5′-GGAAAGATGAGACCACCCGTGAAAC-3′;
Reverse: 5′-GGAAGACCTCGTTCTGTAAGGAGCATG-3′;
Staufen2:
Forward 5′-GGAATGAACCCCATTAGCCGC-3′;
Reverse 5′-GCTTAGAGTTGTGCCAGAGGTC-3′;
18S:
Forward 5′-AGGATTTGACGGAAGGGCACCAC-3′;
Reverse 5′-GTGCAGCCCCGGACATCTAGGG-3′.
PCR reaction conditions included a denaturing step at 95 °C for 3
min, and ampliﬁcation cycles were limited to within an experimen-
tally determined linear range (Staufen1 — 30 cycles; Staufen2 — 30
cycles; 18S — 20 cycles) of 94 °C for 1 min, Tα °C (Staufen1 — 68 °C,
Staufen2— 58 °C,18S— 60 °C) for 1min and 72 °C for 2min, and a ﬁnal
extension step of 72 °C for 12 min. Negative controls, which lacked RT
during the preparation of the cDNAwere included tomonitor genomic
contamination. The cDNA products were separated by electrophoresis
on 1.5% (w/v) agarose gels, visualised under UV following ethidium
bromide staining and the DNA sequences conﬁrmed by sequencing.
Endogenous mRNA levels of the pluripotency markers Oct4 & Na-
nogweremeasured on equivalent amounts of DNAse treated total RNA
by real-time using a Roche LightCycler 480 and SYBR Green PCR
master mix (Roche). Primers used for the real-time PCR are shown:
OCT 4: F5′-CCTGGGAAAGGTGTCCTGTA-3′: R5′-CCAATCAGCT-
TGGGCTAGAG-3′;
NANOG: F5′-ACCCTCAAACTCCTGGTCCT-3′: R5′-CACCCACCCATGC-
TAGTCTT-3′.
The thermal proﬁle for PCR consisted of 94 °C for 2 min, 35 cycles of
94 °C for 30 s, 55.5 °C for 45 s, 72 °C for 1 min and ﬁnally 2 min at 72 °C.
Samples and negative controls were analysed in triplicate and the
amount of mRNA normalised to 18S rRNA.
2.4. Embryo recovery
MF1 female mice (3–4 weeks; Olac) were superovulated by intra-
peritoneal injections of 5 iu of pregnant mares serum gonadotrophin
Fig. 2. Staufen gene expression and synthesis in mouse ES cells (mESC). (A) RT-PCR
analysis of total RNA extracted frommouse brain tissue and mES cells for Staufen1 (S1),
Staufen2 (S2) and 18S gene expression. RNA indicates negative control (no reverse
transcriptase (RT)). (B) Western blot analysis of protein extracts prepared from
undifferentiated mES cells (mESC) (30 μg per lane), IEC-6 cells (30 and 15 μg per lane)
and Caco-2 cells (30 μper lane) using anti-Staufen antibody (in the rodent IEC-6 cell line
Staufen64 was detected while in the human Caco-2 cell line Staufen55 was detected). (C)
Immunocytochemical staining of aggregates of undifferentiated mouse ES cells using
anti-Staufen antibody (arrow indicates cytoplasmic staining).
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apart, paired with males of the same strain and inspected the following
day for vaginal plugs as an indication of successful mating. Fertilised
zygotes, late 2-cell, 4-cell, 8-cell and blastocyst stage embryos were
recovered by ﬂushing directly into the Flushing HoldingMedium (FHM;
Speciality Media). After a brief exposure to acid tyrodes (Sigma) to
remove zonae, the embryos were transferred to Potassium Simplex
Optimised Media (KSOM; Speciality Media) and allowed to recover
brieﬂy at 37 °C in 5% CO2. Unfertilised mouse eggs were isolated from
non-paired superovulated females 12 h post hCG treatment. Disaggre-
gated cells were obtained by culturing dezonaed 4-cell stage blasto-
meres in calcium free medium.
2.5. Immunocytochemistry
For all immunocytochemical analyses a speciﬁc rabbit anti-Staufen
antibody, raised against recombinant mouse Staufen1 (domains 2–4),
was used [30].
Mouse ES cells seeded (4×104 cells/gelatin coated well) and
cultured in a 8-well Nunc Lab-Tek® Chamber Slide™ system on
Permanox (Sigma), were washed three times in phosphate buffered
saline (PBS), ﬁxed in 4% paraformaldehyde and permeabilised by
treatment with 0.05% Triton and 1% paraformaldehyde. After washing,
the cells were blocked with 5% BSA and incubated overnight at 4 °C
with the rabbit anti-Staufen antibody diluted 1:200 in PBS containing
0.5% BSA. After further washing, the cells were incubated with either
goat anti-rabbit FITC (Sigma) or goat anti-rabbit rhodamine (Chemi-
con) secondary antibodies diluted as appropriate in 0.5% BSA. After aFig. 1. Western blot and immunocytochemical analysis of immunoreactive Staufen in
preimplantation mouse embryos and blastocysts. (A) Western blot analysis of protein
extracts (100 eggs/embryos per analysis) for immunoreactive Staufen using rabbit anti-
Staufen diluted 1:1000: lane 1, unfertilised eggs; lane 2, 2-cell embryos; lane 3, 4-cell
embryos; lane 4, 8-cell embryos; lane 5, blastocysts. (B) Western blot analysis of protein
extracts from blastocyst using rabbit anti-Staufen diluted 1:1000 alone or pre-adsorbed
by incubation with recombinant mouse Staufen1 protein linked to Sepharose4B.
Immunocytochemical staining of mouse embryos using anti-Staufen antibody: 4-cell
stage embryos (C); blastocyst (D); disaggregated cells from 4-cell stage blastomere
undergoing cell division and stained with anti-Staufen (FITC) and anti-tubulin (Texas
Red); yellow staining represents co-localisation of the two proteins (E).ﬁnal wash the cells were mounted in Citiﬂuor and staining examined
using an Olympus BX51 ﬂuorescence microscope.
Preimplantation embryos were processed for immunocytochem-
istry, and incubated overnight at 4 °Cwith either anti-Staufen antibody
diluted 1:100 in PBS and/or anti-tubulin antibody (Molecular Probes)
diluted 1:1000 in PBS. Embryos were washed in PBS (3×10 min) and
then incubated with either goat anti-rabbit FITC (Staufen) and/or
donkey anti-mouse Texas Red (tubulin) secondary antibodies (Jackson
Immuno Research laboratories Inc), diluted as appropriate for 1 h at
room temperature. After washing (3×10min) in PBS the samples were
mounted in medium plus DAPI (Vectashield H-1200). All stained
embryos were analysed on a standard Biorad radiance confocal
microscope. All images were processed using Lazersharp software.
2.6. Western analysis
To prepare protein extracts, mES cells and embryoid bodies were
scraped from the ﬂasks or dishes, washed in ice-cold PBS containing a
protease inhibitor cocktail (Sigma), and centrifuged for 15 min at
13,000×g and 4 °C. Cell pellets were resuspended in lysis buffer
(100 mM NaCl, 10 mM Tris–HCl, pH 7.6, 1 mM EDTA containing
protease inhibitor), added to an equal volume of SDS sample buffer
(0.225 M Tris–HCl pH6.8, 50% (v/v) glycerol, 5% (w/v) SDS, 0.25 M
dithiothreitol, 0.05% (w/v) bromophenol blue) and heated for 10 min
at 100 °C. Lysate proteins (30 μg) were separated using 10% SDS–
polyacrylamide gel electrophoresis (PAGE) gels and transferred
electrophoretically onto a polyvinylidene diﬂuoride (PVDF) mem-
branes (Roche). Membranes were blocked for 2 h with PBS containing
5% dried milk powder, and incubated overnight with either rabbit
anti-Staufen diluted 1:8000, rabbit anti-GAPDH (1:1000) (Afﬁnity
BioReagents), rabbit anti-DDX4/MVH (Mouse Vasa Homolog or Vasa)
(1:500) (Abcam), goat anti-Brachyury (1:1000), goat anti-Pax6 (1:200)
or goat anti-αfetoprotein (1:1000) (all Santa Cruz). After washing in
PBS containing 0.1% Tween 20 the appropriate goat anti-rabbit
(1:5000) or rabbit anti-goat (1:50 000) HRP-conjugated secondary
antibodies (Amersham) diluted in PBS containing 0.5% dried milk
Fig. 3. Time course (days 2 to 14) of Staufen gene expression and protein synthesis
during embryoid body (EB) formation. (A) RT-PCR analysis of total RNA for Staufen1
(S1), Staufen2 (S2) and 18S gene expression at days 2 to 14 of EB formation. PCR was
carried out using 30 ampliﬁcation cycles for Staufen 1 and 2 and 20 cycles for 18S. The
negative control contained RNA but no RT. (B) Western blot analysis of EB protein
extracts (30 μg per lane) for immunoreactive Staufen using rabbit anti-Staufen diluted
1:8000 and GAPDH using rabbit anti-GAPDH diluted 1:1000.
Fig. 4. Western blot analysis of the effects of Staufen1 gene knockdown on mES cell
differentiation. mES cells were transfected with either Staufen1 or control siRNAs at day
0 and the cells allowed to differentiate. The transfected cells were collected every 2 days
and the protein extracts analysed by western blot for immunoreactive Staufen,
Brachyury, α-fetoprotein (AFP), Pax6, Vasa (MVH) and GAPDH using the appropriate
antibodies. Knockdown of Staufen1 protein expression was observed at days 2 and 4.
Expression of the different lineage markers was transient and knockdown of their
expression was observed at day 2 (Vasa), day 6 (Brachyury and Pax6) and day 8 (AFP).
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using an ECL plus kit (Amersham Bioscience). Bands were analysed by
densitometry using a Geldoc 1000 documentation system (Biorad).
Mouse embryos were washed in PBS containing 5 mg/ml
polyvinylpyrroline and added directly to the SDS sample buffer.
Proteins were separated using 10% SDS–PAGE gels and transferred
overnight at 30 V to PVDFmembranes (NEN), using awet western blot
apparatus (Biorad). Blots were blocked using PBS containing 0.1%
normal goat serum (Vector Labs) and 1% dried milk powder for 1 h at
room temperature, and incubated for a further 4 h at room
temperature with anti-Staufen antibody diluted 1:1000 in blocking
buffer. Membranes were washed (3×10 min) in PBS containing 0.1%
Tween 20 prior to a 1 h incubation in goat anti-rabbit HRP-conjugated
secondary antibody (Amersham International). Membranes were
washed in PBS (3×10 min) and antibody protein complexes visualized
using ECL Plus.
2.7. Flow cytometry
2.7.1. Anti-SSEA-1 Analyses
mES cells cultured on six well plates were collected as a single cell
suspension following disruption by trypsin and resuspended in PBS
+FCS to a ﬁnal density of 106 cells/ml. A total of 100 μl of the
suspension was incubated in the dark for 30 min with a 1:10 dilution
of mouse (SSEA-1, stage-speciﬁc embryonic antigen-1) antibody
(Chemicon), washed three times in the BD FACSTM Lyse/Wash
Assistant (BD), and incubated with a 1:20 dilution of goat anti-
mouse IgM FITC-conjugated secondary antibody for 15min. Cells were
again washed once in the BD FACSTM Lyse/Wash Assistant before
being analysed using FACS Calibur (BD) and the CellQuest software. A
total of 10,000 events were acquired for each sample.
2.7.2. Cell cycle analyses
Cell cycle analysis was performed using the CycleTEST™ PLUS DNA
Reagent Kit (Becton Dickinson). ES cells were harvested by trypsinisa-
tion and counted. Some 5×105 cells were ﬁxed, permeabilised and
stained in accordance with the manufacturer's instructions, and the
sample was analysed by ﬂow cytometry (Becton Dickinson FACSvantage) measuring FL2 area versus total counts. Data were analysed
using ModFit3 software to generate percentages of cells in the G0/G1
phases.
3. Results
3.1. Staufen analyses in the preimplantation mouse embryo
The expression of Staufen has previously been reported in male
and female mouse germ cells [18], but its synthesis and cellular
localisation during early mammalian development have not been
established. To investigate this further, preimplantation mouse
embryos were analysed for Staufen by western blot analysis and
immunocytochemistry. These analyses used a Staufen antibody, raised
against recombinant mouse Staufen1 protein, which detects two
immunoreactive proteins of approximately 64 kDa and 55 kDa
respectively [30]. As shown in Fig. 1A western blotting of protein
extracts from 1-cell, 2-cell, 4-cell, and 8-cell stagemouse embryos and
blastocysts showed a dominant immunoreactive band of approxi-
mately 64 kDa. This bandwas not evident when the antibodywas pre-
adsorbed with recombinant Staufen1 (Fig. 1B). Immunocytochemistry
of disaggregated 4-cell embryos and blastocysts conﬁrmed that
Staufen was present in the cytoplasm of cells at the 4-cell and
blastocyst stages (Fig. 1C, D) although there was no evidence for
asymmetrical staining. Staufen has however been shownpreviously to
bind tubulin [21] and staining of the cells with anti-Staufen and anti-
tubulin antibodies suggested a high degree of co-localisation of the
two proteins. This was particularly marked in disaggregated 4-cell
blastomeres where Staufenwas observed to be associated with micro-
tubular structures as well as present in the nucleus (Fig. 1E).
3.2. Staufen expression and synthesis within mouse ES cells
The in vivo analyses indicated that Staufen was synthesised in
mouse embryos. To further investigate potential roles of Staufen in cell
lineage determination we employed the mouse ES cell line CGR8,
established from the inner cell mass of a 3.5 day male preimplantation
mouse embryo, and which retains the ability to participate in normal
embryonic development [31].
RNA extracted from the undifferentiatedmES cells and analysed for
Staufen gene expression by RT-PCR revealed cDNAbands of 500 bp (S1)
and400bp (S2) respectively (Fig. 2A), consistentwith the expression of
both the mouse Staufen1 and Staufen2 genes. To investigate the
presence of Staufen protein within the mouse CGR8 ES cells, western
blot analysis of the lysate proteinswas performed. Compatiblewith the
ﬁndings in the mouse blastocysts an immunoreactive protein band of
approximately 64 kDa was identiﬁed (Fig. 2B). The mES cells growing
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these aggregates showed immunoreactive Staufen to be present in the
cell cytoplasm (Fig. 2C). As observed in the disaggregated mouse
embryo cells, therewas no evidence of an asymmetric staining pattern.
To investigate if Staufen expression altered during lineage
differentiation, the mouse ES cells were induced to differentiate into
embryoid bodies. This method of differentiation has been shown
previously to result in the extra-embryonic mesoderm, endoderm and
ectoderm lineages, as well as primordial germ cells [2,32–34]. RT-PCR
analysis of RNA extracted from the cells at days 2 to 14 indicated that
the Staufen1 and 2 genes were expressed throughout the differentia-
tion period. Semi-quantitative RT-PCR suggested no major changes in
the expression of either genes (Fig. 3A). Western blot analysis of
protein lysates prepared from differentiating cells (days 2 to 12),
detected only one immunoreactive Staufen protein band of approxi-
mately 64 kDa (Fig. 3B).
3.3. Effects of Staufen1 siRNA on mouse ES cell differentiation
To gain insight into the roles and functionality of Staufen1 within
the differentiating mouse ES cells the effects of down-regulatingFig. 5. Expression of markers of pluripotency. (A) Real-time analyses of the effects of Staufen1
left untreated or transfected at day 0 with either Staufen1 or control siRNAs. After 2 days tot
pluripotency marker genes Oct4 and Nanog and normalised to 18S. Statistical signiﬁcance w
Staufen1 gene knockdown on levels of SSEA-1. mES cells were transfected with either Staufe
LIF. Cells were harvested at day 2. The percentage of SSEA-1 positive cells in the gated pop
antibody.Staufen1 gene expression on lineage differentiation were examined
using RNAi technology. The particular siRNA sequences adopted had
already been shown through western blot analysis to achieve a 71%
knockdown of Staufen1 protein in HeLa cells [25]. In the mES cells,
using lipofectamine as the transfection agent, we routinely observed
Staufen1 gene knockdownvalues of N80% in themES cells. Quantitative
analyses of the knockdown data, adjusted for GAPDH levels, indicated
that at days 2 and 4 of lineage differentiation the levels of Staufenwere
reduced to approximately 30% (mean 29±8% (SEM)) and 40% (mean 39
±11%) respectively, of the control values. RT-PCR analysis showed that
knockdownof Staufen 1was not accompanied by Staufen2 knockdown
(data not shown) indicating the speciﬁcity of the knockdown. As the
immunoreactive Staufen protein band was also lowered this indicates
that Staufen 1 is the major paralogue in mES cells. A control siRNA
(siRNAmut) was used routinely to exclude the possibility that the
knockdown effects were due either to the toxicity of the Staufen1
siRNA nucleic acid or to non-speciﬁc affects. This was a mutated
version of the Staufen1 siRNA containing four nucleotide base changes.
A GFP siRNA, in conjunction with the mTert CGR8 cell line, was also
used as an additional negative control as previous reports have shown
that RNAi sequences that recognise control genes such as GFP do notgene knockdown on Oct4 and Nanog gene expression in mES cells. mES cells were either
al RNA extracted from the cells was analysed by real-time PCR for the expression of the
as assessed using the Student's t-test, ⁎Pb0.05 compared to treated cells. (B) Effects of
n1 siRNA or a control siRNA at day 0, or were left untreated and grownwith or without
ulation (indicated by the boxes) was determined by ﬂow cytometry using anti-SSEA-1
Fig. 6. Effects of Staufen1 gene knockdown on mES cell proliferation and cell cycle
parameters. (A) mES cells were seeded in the presence of LIF and either left untreated,
treated with Staufen1 siRNA or Staufen siRNAmut. Cell counts were performed at days 1,
2 and 5 following Staufen1 gene knockdown. Data are presented as mean cell count
±SEM and represent four replicates of two independent knockdown experiments,
⁎Pb0.05. (B) Cell cycle analysis (5×105 cells for each analysis) was performed at days 2
and 5 post-Staufen1 gene knockdown using the CycleTEST™ PLUS DNA Reagent Kit and
ﬂow cytometry. Arrows indicate the sub G0 cell population indicative of apoptosis.
1940 H. Gautrey et al. / Biochimica et Biophysica Acta 1783 (2008) 1935–1942result in either non-speciﬁc effects, changes in cell surface antigen or
cell differentiation [35].
To ensure knockdown of the Staufen1 gene at the earliest point
possible the mES cells were transfected transiently with Staufen1
siRNA at the same time as lineage differentiation was induced.
Appropriate mES cells cultured in parallel were similarly transfected
with either Staufen siRNAmut or GFP siRNA. Western blotting of the
protein lysates for immunoreactive Staufen and an array of lineage
markers indicative of differentiation including Brachyury (mesoderm),
AFP (endoderm), Pax-6 (ectoderm) and MVH or Vasa (a marker of
primordial germ cells), showed that Staufen1 gene knockdown was
associated to reduced protein levels of all the lineage markers tested
(Fig. 4). The different lineage markers were maximally expressed at
different time points. The protein marker Vasa, which was expressed
at day 2 in control cells, showed a 38–50% fall in expression in the
Staufen1 siRNA treated cells compared to the controls. AFP was
strongly expressed at day 8 and the expression was reduced (range
19–25%) in cells treated with the Staufen1 siRNA. Comparable
reductions in the levels of Brachyury (range 20–45%) and Pax6
(range 27–29%) were recorded at day 6. All data represent values from
two independent knockdown experiments except for Staufen where
three knockdowns were performed. These data suggest that in the
mouse ES cells in vitro, knockdown of Staufen1 gene expression
affects an early step in the cell differentiation events that subse-
quently inﬂuence the formation of the mesoderm, ectoderm and
endoderm cell lineages.
3.4. Effects of Staufen1 siRNA on undifferentiated mouse ES cells
3.4.1. Pluripotency
It could be argued that knockdown of Staufen1 gene expression
affected the pluripotency of the mES cells and thus the capacity of the
cells to differentiate into the different cell lineages. To investigate this
further mES cells maintained in the undifferentiated state by the
presence of LIF, were transfected with either Staufen1, the control
siRNAs (siRNAmut or GFP siRNA) or left untreated, and after 2 days
analysed by ﬂow cytometry for the mouse ES cell surface marker
stage-speciﬁc embryonic antigen (SSEA-1) and by real-time PCR for
the expression of the pluripotency marker genes Oct4 and Nanog. No
difference in SSEA-1 protein levels was observed between the treated
mES cell groups (Fig. 5B), with themean percentage of SSEA-1 positive
cells in the untreated, Staufen siRNA and Staufen siRNAmut groups
recorded as 69±3 (SEM)%, 77±4% and 73±2% (data represent values
from three independent knockdown experiments) respectively. As
shown in Fig. 5A elevated expression of the Oct4 and Nanog genes in
the siRNA treated cells compared to the untransfected cells was
observed (Pb0.05). This was probably a non-speciﬁc effect resulting
from the transfection procedure per se. In addition, there was no
signiﬁcant difference in the expression of the Oct4 or Nanog genes
between the two siRNA treated groups (Fig. 5A), indicating no loss of
pluripotency. There was however a trend towards increased Oct4 and
Nanog expression after Staufen1 knockdown.
3.4.2. Cell proliferation
The effects of Staufen1 knockdown on the ability of the mouse ES
cells to proliferate were also investigated. Mouse ES cells were seeded
in the presence of LIF and either left untreated, or treated with
Staufen1 siRNA or Staufen siRNAmut. At day 1 post transfection there
was no signiﬁcant difference in the viable cell counts between any of
the treatment groups. By day 2, both of the siRNA treated groups
contained reduced numbers of cells compared to the untreated group
(Fig. 6A). This observation was viewed as a reﬂection of the siRNA
transfection process per se [36]. In support, cell cycle analysis carried
out on cells grown for 2 and 5 days after transfection with siRNAs
displayed a small sub Go shoulder (Fig. 6B), indicative of apoptosis,
with the number of apoptotic cells calculated in each group, 11%(Staufen siRNA) and 12% (Staufen siRNAmut), not being signiﬁcantly
different. By day 5 the cells transfected with the mutated control
siRNA had recovered and the viable cell counts were comparable to
those of the untransfected cells (Fig. 6A). However proliferation of the
cells transfected with the Staufen1 siRNA did not appear to follow the
same recovery patternwith signiﬁcantly lower numbers of cells at day
5 compared to both the untreated controls and the cells transfected
with the control siRNAmut (Pb0.05). This suggested that the
reduction in cell numbers at day 5 was a consequence of the
knockdown of Staufen gene expression rather than the transfection
per se. As microarray analyses and other studies have identiﬁed a
number of Staufen bound mRNAs encoding proteins involved in the
cell cycle [25,26] and/or cell division [37], it was feasible that the
reduced cell numbers were a consequence of the cells growing more
1941H. Gautrey et al. / Biochimica et Biophysica Acta 1783 (2008) 1935–1942slowly due to changes in cell cycle progression [27]. However cell cycle
analyses of day 5 transfected cells did not support this (Fig. 6B),
suggesting that other factors and/or processes were involved.
4. Discussion
Prior to this report two previous studies have hinted at the
importance of Staufen in mammalian cell differentiation. First, the
differentiation of mammalian gut progenitor cells is associated with
the increased expression of genes, including Staufen, encoding
proteins involved in mRNA processing and localisation [38]. Second
the differentiation of myoblasts to myotubes is associated with
increased Staufen-mediated RNA decay [39]. The results of the present
study, in which we show that Staufen is synthesised in the early
mouse embryo and mouse ES cells, and that down-regulation of
Staufen1 gene expression in the mES cells leads to alterations in the
expression of lineage markers associated with differentiation, extend
these observations and provide evidence that Staufen is a key factor in
the initial differentiation events that underpin mammalian develop-
ment. Moreover the data complement previous work where Staufen
has been shown to function during the early development of Droso-
phila, Xenopus and zebraﬁsh [11,15,17,40,41].
Staufen has already been shown to be expressed in mouse germ
cells [18] with elevated gene expression detected in the developing
oocyte and in spermatocytes, speciﬁcally during stages VI–XII of the
spermatogenic cycle. Our molecular analyses using mouse embryos
and mES cells show that Staufen gene expression continues after
fertilisation and the detection of both Staufen1 and 2 transcripts
indicates the potential physiological importance of the two paralogues
in mammalian development. Moreover the use of RNA interference
has provided deﬁnitive evidence for a speciﬁc role for Staufen1 in cell
lineage differentiation. Indeed the 80% knockdown of Staufen1 gene
expression in mES cells forced to differentiate into the mesoderm,
endoderm and ectoderm cell lineages caused a marked reduction in
the synthesis of the classic lineage differentiation markers Brachyury,
AFP and Pax-6 respectively, illustrating key roles for the Staufen1
protein in mES cell differentiation. Although some differentiation of
themES cells still occurred within the Staufen1 siRNA treated group, it
remains to be determined whether this was due either to the
synthesis of small amounts of Staufen1 during the knockdown or
whether in the absence of Staufen1 some differentiation was still able
to occur. As there is also redundancy between the two Staufen
paralogues [26], the possibility that differentiation occurred as a
consequence of the synthesis of Staufen2 cannot be entirely excluded.
It was feasible that the reduction in the synthesis of the lineage
markers of the mouse ES cells could be explained by a loss of
pluripotency. However this was countered by the fact that the
synthesis of the cell surface marker SSEA-1 and the expression of
the Nanog and Oct4 genes, all of which are key markers of
pluripotency, did not change signiﬁcantly during treatment with
Staufen1 siRNA. The trend towards increased expression of pluripo-
tency markers (Fig. 6) was most probably due to the siRNA blocking
differentiation of the small number of cells that continue to
differentiate even in the presence of LIF. The reduction in lineage
markers as a result of Staufen1 knockdown appeared to be a direct
consequence of a block, or stall, in the differentiation process per se.
Signiﬁcantly, as all lineage markers were affected, the mechanism by
which Staufen1 functions appears to be a general one. This is possible
if Staufen is functioning as an RNA binding protein, as the protein does
not bind to dsRNA in a sequence speciﬁc manner [42], and has been
shown to bind to, and affect the fate of, a variety of different mRNAs
[10,26].
In the mouse blastocyst and the mES cells, immunocytochemical
analyses showed Staufen to be present in the cell cytoplasm, which is
consistent with reports in other mammalian cells where tagged
recombinant Staufen proteins have been shown to localise speciﬁcallyto the rough endoplasmic reticulum [20,21]. More recently these
observations have been supported by data in pig oocytes, where the
restricted distribution of endogenous Staufen was reported to occur
during cell maturation, and the pattern of distribution mimicking the
reorganisation of the endoplasmic reticulum [43]. In the present study
staining of the mES cells, and cells isolated from preimplantation
embryos, for immunoreactive Staufen revealed no evidence of
asymmetric staining patterns. However, consistent with observations
in Drosophila [44] and in mammalian cells transfected with Staufen
[21] the protein did appear to associate with microtubules during cell
division indicative of protein and presumably mRNA localisation. This
may be particularly relevant in ES cells since stem cell division is
associated with centrosome asymmetry [8]. However as Staufen is
also known to function inmRNA transport it is feasible that generation
of localised proteins through their synthesis in restricted parts of the
mouse cells could play a role in producing cell asymmetry and the
activation of speciﬁc determinant signalling pathways. Moreover as
Staufen has already been shown to be involved in the asymmetric
division of stem cells in Drosophila [11], this proposal would favour a
conserved mechanism functioning during early development.
Immunocytochemical staining of the mouse blastocyst and the
mES cells provided evidence for the nuclear localisation of Staufen
(Fig. 1E). This observation is consistent with both Staufen1 and 2
containing the appropriate localisation signals [22–24] and reports in
somatic cells where the nuclear import of Staufen1 represents only a
small fraction of the Staufen pool [23]. It is feasible that the nuclear
presence of Staufen reﬂects unique roles and/or functions of the
protein associated with the cleavage of the fertilised mouse egg.
Staufen has been shown to associate with the telomerase RNA–protein
complex [45,46], thus a potential nuclear role for Staufen is in the
maintenance of chromosome stability throughout meiosis and early
embryogenesis. Alternatively this early stage of mammalian develop-
ment may reﬂect a critical role for Staufen in maintaining cell viability
through nonsense-mediated mRNA decay mechanisms.
In summary the data show that Staufen is found in mammalian
preimplantation embryos and functions as a key factor in the in vitro
lineage differentiation of mES cells. Moreover this system provides a
powerful tool with which to further investigate mechanisms, includ-
ing those involving Staufen1, that operate during the mES differentia-
tion process. It will be particularly important to assess if this function
of Staufen1 is conserved in human ES cells.
Acknowledgments
HG was supported by a BBSRC studentship. We thank Professor
Martin Johnson for help in producing the disaggregated mouse
embryo cells.
References
[1] J. Nichols, Introducing embryonic stem cells, Curr. Biol. 11 (2001) R503–505.
[2] I. Desbaillets, U. Ziegler, P. Groscurth, M. Gassmann, Embryoid bodies: an in vitro
model of mouse embryogenesis, Exp. Physiol. 85 (2000) 645–651.
[3] G. Keller, Embryonic stem cell differentiation: emergence of a new era in biology
and medicine, Genes Dev. 19 (2005) 1129–1155.
[4] D.A. Loebel, C.M. Watson, R.A. De Young, P.P. Tam, Lineage choice and
differentiation in mouse embryos and embryonic stem cells, Dev. Biol. 264
(2003) 1–14.
[5] L.A. Boyer, D. Mathur, R. Jaenisch, Molecular control of pluripotency, Curr. Opin.
Genet. Dev. 16 (2006) 455–462.
[6] I. Chambers, J. Silva, D. Colby, J. Nichols, B. Nijmeijer, M. Robertson, J. Vrana, K.
Jones, L. Grotewold, A. Smith, Nanog safeguards pluripotency and mediates
germline development, Nature 450 (2007) 1230–1234.
[7] M.A. Surani, K. Hayashi, P. Hajkova, Genetic and epigenetic regulators of
pluripotency, Cell 128 (2007) 747–762.
[8] H. Lin, Cell biology of stem cells: an enigma of asymmetry and self-renewal, J. Cell
Biol. 180 (2008) 257–260.
[9] J. Betschinger, J.A. Knoblich, Dare to be different: asymmetric cell division in
Drosophila, C. elegans and vertebrates, Curr. Biol. 14 (2004) R674–685.
[10] F. Roegiers, Y.N. Jan, Staufen: a common component of mRNA transport in oocytes
and neurons? Trends Cell Biol. 10 (2000) 220–224.
1942 H. Gautrey et al. / Biochimica et Biophysica Acta 1783 (2008) 1935–1942[11] J. Broadus, S. Fuerstenberg, C.Q. Doe, Staufen-dependent localization of prospero
mRNA contributes to neuroblast daughter-cell fate, Nature 391 (1998) 792–795.
[12] F. Matsuzaki, T. Ohshiro, H. Ikeshima-Kataoka, H. Izumi, Miranda localizes staufen
and prospero asymmetrically in mitotic neuroblasts and epithelial cells in early
Drosophila embryogenesis, Development (Cambridge, England) 125 (1998)
4089–4098.
[13] A.J. Schuldt, J.H. Adams, C.M. Davidson, D.R. Micklem, J. Haseloff, D. St Johnston, A.
H. Brand, Miranda mediates asymmetric protein and RNA localization in the
developing nervous system, Genes Dev. 12 (1998) 1847–1857.
[14] A. Wodarz, Molecular control of cell polarity and asymmetric cell division in
Drosophila neuroblasts, Curr. Opin. Cell Biol. 17 (2005) 475–481.
[15] D. St Johnston, D. Beuchle, C. Nusslein-Volhard, Staufen, a gene required to localize
maternal RNAs in the Drosophila egg, Cell 66 (1991) 51–63.
[16] M.L. King, T.J. Messitt, K.L. Mowry, Putting RNAs in the right place at the right time:
RNA localization in the frog oocyte, Biology of the cell/under the auspices of the
European Cell Biology Organization 97 (2005) 19–33.
[17] S. Ramasamy, H. Wang, H.N. Quach, K. Sampath, Zebraﬁsh Staufen1 and Staufen2
are required for the survival and migration of primordial germ cells, Dev. Biol. 292
(2006) 393–406.
[18] P.T. Saunders, S. Pathirana, S.M. Maguire, M. Doyle, T. Wood, M. Bownes, Mouse
staufen genes are expressed in germ cells during oogenesis and spermatogenesis,
Mol. Hum. Reprod. 6 (2000) 983–991.
[19] T.F. Duchaine, I. Hemraj, L. Furic, A. Deitinghoff, M.A. Kiebler, L. DesGroseillers,
Staufen2 isoforms localize to the somatodendritic domain of neurons and interact
with different organelles, J. Cell Sci. 115 (2002) 3285–3295.
[20] R.M. Marion, P. Fortes, A. Beloso, C. Dotti, J. Ortin, A human sequence homologue of
Staufen is an RNA-binding protein that is associated with polysomes and localizes
to the rough endoplasmic reticulum, Mol. Cell Biol. 19 (1999) 2212–2219.
[21] L. Wickham, T. Duchaine, M. Luo, I.R. Nabi, L. DesGroseillers, Mammalian staufen is
a double-stranded-RNAand tubulin-binding protein which localizes to the rough
endoplasmic reticulum, Mol. Cell Biol. 19 (1999) 2220–2230.
[22] P. Macchi, A.M. Brownawell, B. Grunewald, L. DesGroseillers, I.G. Macara, M.A.
Kiebler, The brain-speciﬁc double-stranded RNA-binding protein Staufen2:
nucleolar accumulation and isoform-speciﬁc exportin-5-dependent export, J.
Biol. Chem. 279 (2004) 31440–31444.
[23] C. Martel, P. Macchi, L. Furic, M.A. Kiebler, L. Desgroseillers, Staufen1 is imported
into the nucleolus via a bipartite nuclear localization signal and several
modulatory determinants, Biochem. J. 393 (2006) 245–254.
[24] T. Miki, Y. Yoneda, Alternative splicing of Staufen2 creates the nuclear export
signal for CRM1 (Exportin 1), J. Biol. Chem. 279 (2004) 47473–47479.
[25] Y.K. Kim, L. Furic, L. Desgroseillers, L.E. Maquat, Mammalian Staufen1 recruits Upf1
to speciﬁc mRNA 3¢UTRs so as to elicit mRNA decay, Cell 120 (2005) 195–208.
[26] L. Furic, M. Maher-Laporte, L. DesGroseillers, A genome-wide approach identiﬁes
distinct but overlapping subsets of cellular mRNAs associated with Staufen1- and
Staufen2-containing ribonucleoprotein complexes, RNA (New York, N.Y) 14
(2008) 324–335.
[27] L. Armstrong, M. Lako, J. Lincoln, P.M. Cairns, N. Hole, mTert expression correlates
with telomerase activity during the differentiation of murine embryonic stem
cells, Mech. Dev. 97 (2000) 109–116.
[28] A.G. Smith, Culture and differentiation of embryonic stem cells, J. Tissue Cult.
Methods 13 (1991) 688–691.
[29] R.L. Williams, D.J. Hilton, S. Pease, T.A. Willson, C.L. Stewart, D.P. Gearing, E.F.
Wagner, D. Metcalf, N.A. Nicola, N.M. Gough, Myeloid leukaemia inhibitory factormaintains the developmental potential of embryonic stem cells, Nature 336
(1988) 684–687.
[30] H. Gautrey, J. McConnell, J. Hall, J. Hesketh, Polarised distribution of the RNA-
binding protein Staufen in differentiated intestinal epithelial cells, FEBS Lett. 579
(2005) 2226–2230.
[31] J. Nichols, E.P. Evans, A.G. Smith, Establishment of germ-line-competent
embryonic stem (ES) cells using differentiation inhibiting activity, Dev. (Cam-
bridge, England) 110 (1990) 1341–1348.
[32] N. Geijsen, M. Horoschak, K. Kim, J. Gribnau, K. Eggan, G.Q. Daley, Derivation of
embryonic germ cells and male gametes from embryonic stem cells, Nature 427
(2004) 148–154.
[33] K. Hubner, G. Fuhrmann, L.K. Christenson, J. Kehler, R. Reinbold, R. De La Fuente, J.
Wood, J.F. Strauss 3rd, M. Boiani, H.R. Scholer, Derivation of oocytes from mouse
embryonic stem cells, Science (New York, N.Y.) 300 (2003) 1251–1256.
[34] G. Yamada, C. Kioussi, F.R. Schubert, Y. Eto, K. Chowdhury, F. Pituello, P. Gruss,
Regulated expression of Brachyury(T), Nkx1.1 and Pax genes in embryoid bodies,
Biochem. Biophys. Res. Commun. 199 (1994) 552–563.
[35] L. Hyslop, M. Stojkovic, L. Armstrong, T. Walter, P. Stojkovic, S. Przyborski, M.
Herbert, A. Murdoch, T. Strachan, M. Lako, Downregulation of NANOG induces
differentiation of human embryonic stem cells to extraembryonic lineages, Stem
Cells (Dayton, Ohio) 23 (2005) 1035–1043.
[36] S. Spagnou, A.D. Miller, M. Keller, Lipidic carriers of siRNA: differences in the
formulation, cellular uptake, and delivery with plasmid DNA, Biochemistry 43
(2004) 13348–13356.
[37] C. Slack, P.M. Overton, R.I. Tuxworth, W. Chia, Asymmetric localisation of Miranda
and its cargo proteins during neuroblast division requires the anaphase-
promoting complex/cyclosome, Development (Cambridge, England) 134 (2007)
3781–3787.
[38] J.C. Mills, N. Andersson, C.V. Hong, T.S. Stappenbeck, J.I. Gordon, Molecular
characterization of mouse gastric epithelial progenitor cells, Proc. Natl. Acad. Sci.
U. S. A. 99 (2002) 14819–14824.
[39] Y.K. Kim, L. Furic, M. Parisien, F. Major, L. DesGroseillers, L.E. Maquat, Staufen1
regulates diverse classes of mammalian transcripts, The EMBO J. 26 (2007)
2670–2681.
[40] R. Allison, K. Czaplinski, A. Git, E. Adegbenro, F. Stennard, E. Houliston, N. Standart,
Two distinct Staufen isoforms in Xenopus are vegetally localized during oogenesis,
RNA (New York, N.Y.) 10 (2004) 1751–1763.
[41] Y.J. Yoon, K.L. Mowry, Xenopus Staufen is a component of a ribonucleoprotein
complex containing Vg1 RNA and kinesin, Development (Cambridge, England) 131
(2004) 3035–3045.
[42] A. Ramos, S. Grunert, J. Adams, D.R. Micklem, M.R. Proctor, S. Freund, M. Bycroft, D.
St Johnston, G. Varani, RNA recognition by a Staufen double-stranded RNA-
binding domain, The EMBO J. 19 (2000) 997–1009.
[43] T.A. Brevini, F. Cillo, S. Antonini, F. Gandolﬁ, Cytoplasmic remodelling and the
acquisition of developmental competence in pig oocytes, Animal reproduction
science 98 (2007) 23–38.
[44] D.R. Micklem, J. Adams, S. Grunert, D. St Johnston, Distinct roles of two conserved
Staufen domains in oskar mRNA localization and translation, The EMBO J. 19
(2000) 1366–1377.
[45] F. Bachand, I. Triki, C. Autexier, Human telomerase RNA–protein interactions,
Nucleic Acids Res. 29 (2001) 3385–3393.
[46] S. Le, R. Sternglanz, C.W. Greider, Identiﬁcation of two RNA-binding proteins
associated with human telomerase RNA, Mol. Biol. Cell 11 (2000) 999–1010.
